Press Releases

Accellix Inc. and Streck collaborate to advance cell therapy with quality control San Jose, CA and La Vista, NE – Accellix™, a pioneer in automated flow cytometry, and Streck, a… Read more: Accellix Inc. and Streck collaborate to advance cell therapy with quality control

Streck launches new MDx-Chex® controls for molecular diagnostic assays La Vista, Nebraska – Streck is excited to announce the release of the newest additions to the MDx-Chex® line of molecular… Read more: Streck launches new MDx-Chex controls for molecular diagnostic assays

Streck launches Liquid Biopsy Accelerator Grant to advance non-invasive cancer detection research La Vista, Nebraska – Streck is thrilled to announce the launch of its inaugural Liquid Biopsy Accelerator Grant.… Read more: Streck launches Liquid Biopsy Accelerator Grant to advance non-invasive cancer detection research

Streck releases improved ARM-D® Kit, OXA with expanded coverage in three new OXA gene families La Vista, Nebraska – Streck is excited to announce the release of an updated version… Read more: Streck releases improved ARM-D Kit, OXA with expanded coverage in three new OXA gene families

Connie Ryan announces retirement from Streck La Vista, Nebraska – After 42 years of dedicated service, Connie Ryan has announced her retirement from Streck. Since joining the company in 1982,… Read more: Connie Ryan announces retirement from Streck

  Streck launches Protein Plus BCT for stabilization of plasma proteins in whole blood   La Vista, Nebraska – Streck is pleased to announce the launch of Protein Plus BCTTM,… Read more: Streck launches Protein Plus BCT for stabilization of plasma proteins in whole blood

MDx-Chex® for BC-GP and BC-GN, new full-process, molecular diagnostics quality controls for bloodstream infections, receive FDA clearance La Vista, Nebraska – Streck is pleased to announce that MDx-Chex® for BC-GP… Read more: MDx-Chex for BC-GP and BC-GN Launch

Streck’s first-of-its-kind molecular diagnostics quality control MDx-Chex for BCID2 receives FDA clearance La Vista, NE –Streck is pleased to announce MDx-Chex™ for BCID2, a first-of-its-kind quality control designed to meet… Read more: Streck’s first-of-its-kind molecular diagnostics quality control MDx-Chex for BCID2 receives FDA clearance

Streck is pleased to announce MDx-Chex™ for BCID2, a first-of-its-kind quality control designed to meet the standards for verifying the performance of sample-to-result molecular tests for sepsis. MDx-Chex for BCID2 is For Research Use Only. Not for use in diagnostic procedures.

Streck Cell-Free DNA BCT received U.S. Food and Drug Administration De Novo clearance for In Vitro Diagnostic use when paired with the Guardant360 CDx liquid biopsy assay. Cell-Free DNA BCT is the first and only circulating nucleic acid blood collection tube to be cleared for use with liquid biopsy.

Biodesix, Inc. and Streck, Inc. today announced a Regulatory Cooperation Agreement that will further enable both companies in their pursuit of FDA approval for diagnostic testing services and specimen collection products.